Systematic literature review of the disease burden and vaccination of pneumococcal disease among adults in select Asia-Pacific areas

References

• World Health Organization. Pneumococcal disease [July 10, 2020]. Available from: https://www.who.int/immunization/diseases/pneumococcal/en/
   Google Scholar
• Drijkoningen JJC, Rohde GGU. Pneumococcal infection in adults: burden of disease. Clin Microbiol Infect. 2014;20:45–51.
   PubMed Web of Science ®Google Scholar
• Hung IF-N, Tantawichien T, Tsai YH, et al. Regional epidemiology of invasive pneumococcal disease in Asian adults: epidemiology, disease burden, serotype distribution, and antimicrobial resistance patterns and prevention. Inter J Infect Dis. 2013;17(6):e364–e373.
   PubMed Web of Science ®Google Scholar
• Dadonaite B, Roser M. Pneumonia. 2019 [2020 Jul 10]. Available from: https://ourworldindata.org/pneumonia
   Google Scholar
• Song JH, Oh WS, Kang CI, et al. Epidemiology and clinical outcomes of community-acquired pneumonia in adult patients in Asian countries: a prospective study by the Asian network for surveillance of resistant pathogens. Int J Antimicrob Agents. 2008;31(2):107–114.
   PubMed Web of Science ®Google Scholar
• Troeger C, Blacker B, Khalil IA, GBD Lower Respiratory Infections Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. 2018;18(11):1191–1210.
   PubMed Web of Science ®Google Scholar
• Tereziu S, Minter DA. Pneumococcal Vaccine. StatPearls. Treasure Island (FL): StatPearls Publishing; 2021.
   Google Scholar
• Wang Y, Li J, Wang Y, et al. Effectiveness and practical uses of 23-valent pneumococcal polysaccharide vaccine in healthy and special populations. Hum Vaccin Immunother. 2018;14(4):1003–1012.
   PubMed Web of Science ®Google Scholar
• Chen C, Cervero Liceras F, Flasche S, et al. Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis. Lancet Glob Health. 2019;7(1):e58–e67.
   PubMed Web of Science ®Google Scholar
• Eng P, Lim LH, Loo CM, et al. Role of pneumococcal vaccination in prevention of pneumococcal disease among adults in Singapore. Int J Gen Med. 2014;7:179–191.
   PubMedGoogle Scholar
• Williams SR, Driscoll AJ, LeBuhn HM, et al. National routine adult immunisation programmes among world health organization member states: an assessment of health systems to deploy COVID-19 vaccines. Euro Surveill. 2021;26(17). DOI:https://doi.org/10.2807/1560-7917.ES.2021.26.17.2001195.
   Google Scholar
• International Federation on Ageing. Adult vaccination in the Asia Pacific: mobilizing policy and practice knowledge 2019 cited 2020 Aug 14. Available from: https://ifa.ngo/wp-content/uploads/2019/10/Adult-Vaccination-in-the-Asia-Pacific-%E2%80%93-Mobilizing-Policy-and-Practice-Knowledge.pdf
   Google Scholar
• Chinese Preventive Medicine Association. Expert consensus on immunoprophylaxis of pneumococcal disease (2020 version). Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(12):1945–1979.
   PubMedGoogle Scholar
• Chen K, Zhang X, Shan W, et al. Serotype distribution of Streptococcus pneumoniae and potential impact of pneumococcal conjugate vaccines in China: a systematic review and meta-analysis. Hum Vaccin Immunother. 2018;14(6):1453–1463.
   PubMed Web of Science ®Google Scholar
• Ishiwada N. Current situation and need for prevention of invasive pneumococcal disease and pneumococcal pneumonia in 6- to 64-year-olds in Japan. J Infect Chemother. 2021;27(1):7–18.
   PubMed Web of Science ®Google Scholar
• Katoh S, Suzuki M, Ariyoshi K, et al. Serotype replacement in adult pneumococcal pneumonia after the introduction of seven-valent pneumococcal conjugate vaccines for children in Japan: a systematic literature review and pooled data analysis. Jpn J Infect Dis. 2017;70(5):495–501.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
   PubMed Web of Science ®Google Scholar
• Centre for Reviews and Dissemination. Systematic Reviews. CRD’s Guidance for Undertaking Reviews in Health Care 2009 [2018 Apr 2]. Available from: http://www.york.ac.uk/media/crd/Systematic_Reviews.pdf.
   Google Scholar
• Chan T, Tay MZ, Kyaw WM, et al. Epidemiology, vaccine effectiveness, and risk factors for mortality for pneumococcal disease among hospitalised adults in Singapore: a case-control study. BMC Infect Dis. 2020;20(1):423.
   PubMed Web of Science ®Google Scholar
• Torda A, Chong Q, Lee A, et al. Invasive pneumococcal disease following adult allogeneic hematopoietic stem cell transplantation. Transplant Infect Dis. 2014;16(5):751–759.
   PubMed Web of Science ®Google Scholar
• Roberts MB, Bak N, Wee LYA, et al. Clinical effectiveness of conjugate pneumococcal vaccination in hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transplant. 2020;26(2):421–427.
   PubMed Web of Science ®Google Scholar
• Roberts MB, Hiwase DK, Bak N. Conjugate pneumococcal vaccination reduces invasive pneumococcal disease post haemotopoietic stem cell transplant. Open Forum Infect Dis. 2018;5:S491.
   Google Scholar
• Chiou W-Y, Hung S-K, Lai C-L, et al. Effect of 23-valent pneumococcal polysaccharide vaccine inoculated during anti-cancer treatment period in elderly lung cancer patients on community-acquired pneumonia hospitalization: a nationwide population-based cohort study. Medicine (Baltimore). 2015;94(26):e1022.
   PubMed Web of Science ®Google Scholar
• Chiou W-Y, Hung S-K, Lin H-Y, et al. Effectiveness of 23-valent pneumococcal polysaccharide vaccine on elderly patients with colorectal cancer: a population-based propensity score-matched cohort study. Medicine (Baltimore). 2019;98(50):e18380.
   PubMed Web of Science ®Google Scholar
• Chiou W-Y, Lee M-S, Hung S-K, et al. Effectiveness of 23-valent pneumococcal polysaccharide vaccine on elderly long-term cancer survivors: a population-based propensity score matched cohort study. BMJ Open. 2018;8(5):e019364.
   PubMed Web of Science ®Google Scholar
• Kuo C-S, Lu C-W, Chang Y-K, et al. Effectiveness of 23-valent pneumococcal polysaccharide vaccine on diabetic elderly. Medicine (USA). 2016;95(26):e4064.
   PubMed Web of Science ®Google Scholar
• Faudzi YA. Risk of acquiring pneumonia among the Malaysian hajj pilgrims vaccinated with 23 valent pneumococcal vaccine. Med J Malaysia. Medical Journal of Malaysia. 2017;72:38.
   Google Scholar
• Memish ZA, Assiri A, Almasri M, et al. Impact of the Hajj on pneumococcal transmission. Clin Microbiol Infect. 2015;21(1):77.e11–8.
   Google Scholar
• Liao WH, Lin SH, Lai CC, et al. Impact of pneumococcal vaccines on invasive pneumococcal disease in Taiwan. Eur J Clin Microbiol Infect Dis. 2010;29(4):489–492.
   PubMed Web of Science ®Google Scholar
• Hanna JN, Humphreys JL, Murphy DM, et al. Invasive pneumococcal disease in non-Indigenous people in north Queensland, 2001-2009. Med J Aust. 2010;193(7):392–396.
   PubMed Web of Science ®Google Scholar
• Izurieta P, Bahety P, Adegbola R, et al. Public health impact of pneumococcal conjugate vaccine infant immunization programs: assessment of invasive pneumococcal disease burden and serotype distribution. Expert Rev Vaccines. 2018;17(6):479–493.
   PubMed Web of Science ®Google Scholar
• Chi H-C, Hsieh Y-C, Tsai M-H, et al. Impact of pneumococcal conjugate vaccine in children on the serotypic epidemiology of adult invasive pneumococcal diseases in Taiwan. J Microbiol Immunol Infect. 2018;51(3):332–336.
   PubMedGoogle Scholar
• Bareja C, Toms C, Lodo K, et al. Invasive pneumococcal disease in Australia, 2009 and 2010. Commun Dis Intell Q Rep. 2015;39(2):E265–E279.
   PubMed Web of Science ®Google Scholar
• Toms C, de Kluyver R. Invasive pneumococcal disease in Australia, 2011 and 2012. Commun Dis Intell Q Rep. 2016;40(2):E267–E284.
   PubMed Web of Science ®Google Scholar
• Heo JY, Seo YB, Choi WS, et al. Incidence and case fatality rates of community-acquired pneumonia and pneumococcal diseases among Korean adults: catchment population-based analysis. PLoS ONE. 2018;13(3):e0194598.
   PubMed Web of Science ®Google Scholar
• Chiang C-S, Chen -Y-Y, Jiang S-F, et al. National surveillance of invasive pneumococcal diseases in Taiwan, 2008-2012: differential temporal emergence of serotype 19A. Vaccine. 2014;32(27):3345–3349.
   PubMed Web of Science ®Google Scholar
• Rhodes J, Dejsirilert S, Maloney SA, et al. Pneumococcal bacteremia requiring hospitalization in rural thailand: an update on incidence, clinical characteristics, serotype distribution, and antimicrobial susceptibility, 2005-2010. PLoS ONE. 2013;8(6):e66038.
   PubMed Web of Science ®Google Scholar
• Dirmesropian S, Liu B, Wood JG, et al. Pneumonia hospitalisation and case-fatality rates in older australians with and without risk factors for pneumococcal disease: implications for vaccine policy. Epidemiol Infect. 2019;47:147.
   Google Scholar
• Jacups SP, Cheng A. The epidemiology of community acquired bacteremic pneumonia, due to streptococcus pneumoniae, in the top end of the northern territory, Australia-over 22 years. Vaccine. 2011;29(33):5386–5392.
   PubMed Web of Science ®Google Scholar
• Piralam B, Tomczyk SM, Rhodes JC, et al. Incidence of pneumococcal pneumonia among adults in rural Thailand, 2006-2011 implications for pneumococcal vaccine considerations. Am J Trop Med Hyg. 2015;93(6):1140–1147.
   PubMed Web of Science ®Google Scholar
• Kim SH, Bae IK, Park D, et al. Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Isolates Causing Invasive and Noninvasive Pneumococcal Diseases in Korea from 2008 to 2014. Biomed Res Int. 2016;2016:6950482.
   PubMed Web of Science ®Google Scholar
• Kim SH, Chung DR, Song JH, et al. Changes in serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates from adult patients in Asia: emergence of drug-resistant non-vaccine serotypes. Vaccine. 2020;38(38):6065–6073.
   PubMed Web of Science ®Google Scholar
• Said WF, Sukoto E, Khoeri MM, et al. Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae isolates from adult patients in Jakarta, Indonesia. J Infect Public Health. 2017;10(6):833–835.
   PubMed Web of Science ®Google Scholar
• Pennington K. Invasive pneumococcal disease surveillance, 1 july to 30 september 2019. Communicable diseases intelligence. 2018;2020:44.
   Google Scholar
• Wattal C, Goel N, Byotra SP. Prevalence of pneumococcal serotypes in adults ≥50 years of age. Indian J Med Microbiol. 2017;35(1):95–100.
   PubMed Web of Science ®Google Scholar
• Kim JH, Baik SH, Song JY, et al. Clinical characteristics of primary pneumococcal bacteremia in adult patients in the Republic Of Korea. Open Forum Infect Dis. 2016;3. DOI:https://doi.org/10.1093/ofid/ofw172.795.
   Google Scholar
• Kim SH, Chung DR, Baek JY, et al. Changes in serotype distribution of Streptococcus pneumonia isolates from adult patients with invasive pneumococcal disease or pneumonia in Korea. Int J Antimicrob Agents. 2015;45:S99.
   PubMed Web of Science ®Google Scholar
• Kim SH, Chung DR, Baek JY, et al. Serotype and genotype distribution of macrolide resistant Streptococcus pneumonia isolates from adult patients in Korea. Int J Antimicrob Agents. 2015;45:S99.
   PubMed Web of Science ®Google Scholar
• Lee M-C, Kuo K-C, Lee C-H, et al. The antimicrobial susceptibility in adult invasive pneumococcal disease in the era of pneumococcus vaccination: a hospital-based observational study in Taiwan. J Microbiol Immunol Infect. 2020;53(6):836–844.
   PubMedGoogle Scholar
• Kim JH, Baik SH, Chun BC, et al. Adult invasive pneumococcal disease in the Republic Of Korea: risk medical conditions and mortality stratified by age group. Inter J Infect Dis. 2018;74:136–144.
   PubMed Web of Science ®Google Scholar
• Thomas K, Mukkai Kesavan L, Veeraraghavan B, et al. Invasive pneumococcal disease associated with high case fatality in India. J Clin Epidemiol. 2013;66(1):36–43.
   PubMed Web of Science ®Google Scholar
• Man MY, Shum HP, Jsy Y, et al. Burden of pneumococcal disease: 8-year retrospective analysis from a single centre in Hong Kong. Hong Kong Med J. 2020. DOI:https://doi.org/10.12809/hkmj208373.
   Google Scholar
• Jayaraman R, Varghese R, Kumar JL, et al. Invasive pneumococcal disease in Indian adults: 11 years’ experience. J Microbiol Immunol Infect. 2019;52(5):736–742.
   PubMedGoogle Scholar
• Martinez-Vega R, Jauneikaite E, Thoon KC, et al. Risk factor profiles and clinical outcomes for children and adults with pneumococcal infections in Singapore: a need to expand vaccination policy? PLoS ONE. 2019;14(10):e0220951.
   PubMed Web of Science ®Google Scholar
• Song JY, Choi JY, Lee JS, et al. Clinical and economic burden of invasive pneumococcal disease in adults: a multicenter hospital-based study. BMC Infect Dis. 2013;13(1). DOI:https://doi.org/10.1186/1471-2334-13-202.
   Google Scholar
• Wu DB-C, Roberts CS, Huang Y-C, et al. A retrospective study to assess the epidemiological and economic burden of pneumococcal diseases in adults aged 50 years and older in Taiwan. J Med Econ. 2014;17(5):312–319.
   PubMedGoogle Scholar
• Li X, Blais JE, Wong ICK, et al. Population-based estimates of the burden of pneumonia hospitalizations in Hong Kong, 2011-2015. Eur J Clin Microbiol Infect Dis. 2019;38(3):553–561.
   PubMed Web of Science ®Google Scholar
• Lupisan S, Suzuki A, Macalalad N, et al. Etiology and epidemiology of community-acquired pneumonia in adults requiring hospital admission: a prospective study in rural Central Philippines. Inter J Infect Dis. 2019;80:46–53.
   PubMed Web of Science ®Google Scholar
• Yoo KH, Yoo CG, Kim SK, et al. Economic burden and epidemiology of pneumonia in Korean adults aged over 50 years. J Korean Med Sci. 2013;28(6):888–895.
   PubMed Web of Science ®Google Scholar
• Reechaipichitkul W, Thavornpitak Y, Sutra S. Burden of adult pneumonia in Thailand: a nationwide hospital admission data 2010. J Med Assoc Thai. 2014;97(3):283–292.
   PubMedGoogle Scholar
• Dao MD, Nguyen ST, Ha TV, et al. Socioeconomic burden of community-acquired pneumonia associated hospitalizations among Vietnamese patients: a prospective, incidence-based study. Asian J Pharm. 2018;12(1):S38–S47.
   Web of Science ®Google Scholar
• Vo TQ, Bui HT, Tran TPC, et al. Medical expenditures of community-acquired pneumonia hospitalization: a two-year retrospective study from a hospital electronic database in vietnam. J Clin Diagn Res. 2018;12(6):LC38–LC43.
   Web of Science ®Google Scholar
• Rémond MGW, Ralph AP, Brady SJ, et al. Community-acquired pneumonia in the central desert and north-western tropics of Australia. Intern Med J. 2010;40(1):37–44.
   PubMed Web of Science ®Google Scholar
• Tumanan-Mendoza BA, Mendoza VL, Punzalan FER, et al. Economic burden of community-acquired pneumonia among adults in the philippines: its equity and policy implications in the case rate payments of the philippine health insurance corporation. Value Health Reg Issues. 2015;6:118–125.
   PubMedGoogle Scholar
• Rodrigo C, Bewick T, Sheppard C, et al. Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia. Eur Respir J. 2015;45(6):1632–1641.
   PubMed Web of Science ®Google Scholar
• Jain S, Self WH, Wunderink RG, et al. Community-Acquired Pneumonia Requiring Hospitalization among U.S Adults. N Engl J Med. 2015;373(5):415–427.
   PubMed Web of Science ®Google Scholar
• Løchen A, Croucher NJ, Anderson RM. Divergent serotype replacement trends and increasing diversity in pneumococcal disease in high income settings reduce the benefit of expanding vaccine valency. Sci Rep. 2020;10(1):18977.
   PubMed Web of Science ®Google Scholar
• Wang BC, Chaiyakunapruk N, Zhu S, et al. A systematic literature review of economic evaluations of pneumococcal conjugate vaccines in east and Southeast Asia (2006-2019). Expert Rev Vaccines 2021 1–14 https://doi.org/10.1080/14760584.2021.1894933
   Google Scholar
• Australian Government Department of Health. Invasive pneumococcal disease surveillance 2021 cited 2021 Jul 19]. Available from 2021 Jul 19: https://www1.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-nndss-ipd-reports.htm
   Google Scholar
• Singapore National Centre for Infectious Diseases. Communicable diseases surveillance in Singapore 2021 cited 2021 Jul 19]. Available from 2021 Jul 19: https://www.ncid.sg/Health-Professionals/Pages/Communicable-Diseases-Surveillance-in-Singapore.aspx
   Google Scholar
• Zakiyah N, Insani WN, Suwantika AA, et al. Pneumococcal vaccination for children in Asian countries: a systematic review of economic evaluation studies. Vaccines (Basel). 2020;8(3):426.
   Web of Science ®Google Scholar
• Kwambana-Adams BA, Mulholland EK, Satzke C. State-of-the-art in the pneumococcal field: proceedings of the 11(th) international symposium on pneumococci and pneumococcal diseases (ISPPD-11). Pneumonia (Nathan). 2020;12:2.
   PubMedGoogle Scholar